Global Health Research Unit for the Genomic Surveillance of Antimicrobial Resistance, Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
Section of Food Safety and Zoonoses, Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nat Microbiol. 2022 Jun;7(6):757-765. doi: 10.1038/s41564-022-01124-w. Epub 2022 May 30.
Antimicrobial resistance (AMR) is tracked most closely in clinical settings and high-income countries. However, resistant organisms thrive globally and are transmitted to and from healthy humans, animals and the environment, particularly in many low- and middle-income settings. The overall public health and clinical significance of these transmission opportunities remain to be completely clarified. There is thus considerable global interest in promoting a One Health view of AMR to enable a more realistic understanding of its ecology. In reality, AMR surveillance outside hospitals remains insufficient and it has been very challenging to convincingly document transmission at the interfaces between clinical specimens and other niches. In this Review, we describe AMR and its transmission in low- and middle-income-country settings, emphasizing high-risk transmission points such as urban settings and food-animal handling. In urban and food production settings, top-down and infrastructure-dependent interventions against AMR that require strong regulatory oversight are less likely to curtail transmission when used alone and should be combined with bottom-up AMR-containment approaches. We observe that the power of genomics to expose transmission channels and hotspots is largely unharnessed, and that existing and upcoming technological innovations need to be exploited towards containing AMR in low- and middle-income settings.
抗菌素耐药性(AMR)在临床环境和高收入国家中得到了最密切的跟踪。然而,耐药生物在全球范围内大量存在,并在健康人群、动物和环境之间传播,特别是在许多中低收入环境中。这些传播机会对整体公共卫生和临床意义仍有待完全阐明。因此,全球范围内都有相当大的兴趣来促进对 AMR 的一种“同一健康”观点,以便更现实地了解其生态。实际上,医院外的 AMR 监测仍然不足,并且令人信服地记录临床标本和其他生态位之间的传播非常具有挑战性。在这篇综述中,我们描述了中低收入国家环境中的 AMR 及其传播,强调了城市环境和食品动物处理等高风险传播点。在城市和食品生产环境中,单独使用需要强有力的监管监督的针对 AMR 的自上而下和依赖基础设施的干预措施不太可能遏制传播,而应与自下而上的 AMR 遏制方法相结合。我们观察到,基因组学揭示传播渠道和热点的力量在很大程度上尚未被利用,需要利用现有的和即将出现的技术创新来遏制中低收入环境中的 AMR。